Effect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis
Abstract
Hyperlipidemia, characterized by elevated lipid levels, is a major risk factor for cardiovascular diseases (CVD), including atherosclerosis. Tocotrienol-rich fraction (TRF), a potent form of vitamin E, has demonstrated promising lipid-lowering effects due to its antioxidant and anti-inflammatory properties. This systematic review and meta-analysis aimed to evaluate the effects of TRF on lipid profiles in hyperlipidemic experimental animal models and to comparatively assessed their suitability for preclinical research. A total of eight eligible studies published between 2002 and 2024 were included. TRF significantly reduced total cholesterol (effect size = − 4.675, p < 0.0001), LDL (− 4.847, p < 0.0001), and triglycerides (− 4.736, p < 0.0001), while significantly increasing HDL (4.001, p < 0.0001), particularly in rats and mice. Meanwhile, comparative analysis showed that New Zealand white rabbits, hamsters, and genetically modified mice exhibit lipid metabolism profiles closer to humans and respond to lower TRF doses over shorter durations. Conversely, rats, though less prone to diet-induced atherosclerosis, responded well to higher doses over longer periods. However, the predominance of rat studies, absence of standard drug comparators, and variability in dosing and duration limit translational interpretation. Future studies should utilize physiologically relevant models and adopt standardized experimental protocols to better assess TRF’s therapeutic potential in CVD…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.